Related Experiment Video
Updated: Jul 30, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Modest implication of interleukin-6 promoter polymorphisms in longevity
L Christiansen1, L Bathum, K Andersen-Ranberg
1Department of Epidemiology, Institute of Public Health, University of Southern Denmark, Odense, Denmark. lchristiansen@health.sdu.dk
Interleukin-6 (IL-6) gene variations influence aging. The -174GG genotype of IL-6 may promote longevity, suggesting a genetic component to a longer lifespan and healthier aging.
Area of Science:
- Genetics
- Immunology
- Gerontology
Background:
- Interleukin-6 (IL-6) is implicated in chronic inflammation, age-related diseases, and mortality.
- Previous studies on IL-6 promoter polymorphisms and their effects on IL-6 levels and disease susceptibility have yielded conflicting results.
Purpose of the Study:
- To investigate the association between specific interleukin-6 (IL-6) promoter polymorphisms and aging.
- To analyze the frequency of single-point polymorphisms (-597G/A, -572G/C, -174G/C) and the AT-stretch polymorphism (-373(A)n(T)m) in relation to longevity.
Main Methods:
- Genotyping of three single-point polymorphisms and one AT-stretch polymorphism in the IL-6 promoter.
- Analysis of polymorphism and haplotype frequencies in 1710 Danish subjects aged 47-100 years.
Main Results:
- A modest but significant increase in the frequency of interleukin-6 (IL-6) -174GG homozygotes was observed with advancing age.
- This suggests a potential survival advantage associated with the -174GG genotype.
Conclusions:
- The interleukin-6 (IL-6) -174GG genotype may be associated with increased longevity.
- Genetic variations in the IL-6 promoter could play a role in the aging process and lifespan.
More Related Videos
07:25Lipid Supplementation for Longevity and Gene Transcriptional Analysis in Caenorhabditis elegans
Published on: December 9, 2022
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
Related Concept Videos
Non-LTR Retrotransposons
Epigenetic Regulation
X-chromosome...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase